Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series

Malignant glioma (MG) is a common and refractory primary tumor with a high recurrence rate. There is still a lack of effective therapy for recurrent MG (rMG). We present here two cases of refractory rMG treated using apatinib, which is a new highly selective inhibitor to VEGFR. Case 1, a 37-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Honghong, Chen, Fangfang, Wang, Zhiqiang, Wu, Shaoxiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317326/
https://www.ncbi.nlm.nih.gov/pubmed/28243119
http://dx.doi.org/10.2147/OTT.S119129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317326/
https://www.ncbi.nlm.nih.gov/pubmed/28243119
http://dx.doi.org/10.2147/OTT.S119129

Ejemplares similares